N, B., E, M., G, D., M, W., & M, S. (2015). Response to Miller et al: Resistant mutations in CML and Ph(+) ALL – role of ponatinib. Dove Medical Press.
Cita Chicago Style (17a ed.)N, Bardy-Bouxin, Matczak E, Devgan G, Woloj M, y Shapiro M. Response to Miller Et Al: Resistant Mutations in CML and Ph(+) ALL – Role of Ponatinib. Dove Medical Press, 2015.
Cita MLA (8a ed.)N, Bardy-Bouxin, et al. Response to Miller Et Al: Resistant Mutations in CML and Ph(+) ALL – Role of Ponatinib. Dove Medical Press, 2015.
Precaución: Estas citas no son 100% exactas.